NCT06718842 Walking Program in Fatty Liver Children With Phenylketonuria
| NCT ID | NCT06718842 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Phenylketonurias |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-09-15 |
| Primary Completion | 2025-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-09-15 with a primary completion date of 2025-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver
Eligibility Criteria
Inclusion Criteria: * PKU children * obese children * fatty liver children (non-alcoholic fatty liver) Exclusion Criteria: * cardiac children * diabetic children * neurogenic disorders * respiratory and renal problems
Contact & Investigator
Ali Ismail, lecturer
STUDY CHAIR
Cairo University
Frequently Asked Questions
Who can join the NCT06718842 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 12 Years, studying Phenylketonurias. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06718842 currently recruiting?
Yes, NCT06718842 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT06718842 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT06718842 clinical trial?
NCT06718842 is sponsored by Cairo University. The principal investigator is Ali Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.